Posted by: admin on: June 14, 2011
Metformin is a time tested anti diabetic drug. The benefits of this wonder drug still out ways its side effects and those of newer anti diabetic drugs and their combinations. Team@CMHF
Posted by: admin on: May 26, 2011
Patients with type 2 diabetes over a period of time at risk for major depressive disorder over time. Depression is common among patients with type 2 diabetes. This study set out to identify characteristics that predict the onset of major depressive disorder (MDD) among primary care patients with diabetes.
Posted by: admin on: April 28, 2011
Clinicians do not lack for alternative therapies if patients with type 2 diabetes ask to be switched from rosiglitazone (Avandia, GlaxoSmithKline) to another glucose-lowering medication, according to the American Diabetes Association (ADA) and 2 other expert groups. The drug is again under increased scrutiny over cardiovascular risks. Dr. Bergenstal, who also is executive director of […]
Posted by: admin on: April 22, 2011
A structured, supervised exercise program effectively improves HbA1c levels and the cardiovascular risk profile of individuals with diabetes mellitus, a new study shows [1]. The exercise program, a twice-weekly, facility-based regimen that included aerobic exercise, resistance training, and counseling was significantly better at improving HbA1c levels and cardiovascular risk factors than a treatment regimen that […]
Posted by: admin on: April 21, 2011
If possible reductions in medication use and cost can motivate patients to make lifestyle changes, the long-term goals of better health and quality of life can be achieved Action for Health and Diabetes investigators recently reported beneficial effects of 1 year of intensive lifestyle intervention on weight loss, glycemic control, and cardiovascular risk factors. This […]